1) Precipitation over the Yangtze River Basin during the summer of 2020 exhibits pronounced intraseasonal phase ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod in NCP. NCP is a chronic ocular pain syndrome with no FDA-approved therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results